Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Successful preservation and transplant of warm ischaemic lungs from controlled donors after circulatory death by prolonged in situ ventilation during normothermic regional perfusion of abdominal organs.

Palleschi A, Tosi D, Rosso L, Zanella A, De Carlis R, Zanierato M, Benazzi E, Tarsia P, Colledan M, Nosotti M.

Interact Cardiovasc Thorac Surg. 2019 Jun 26. pii: ivz160. doi: 10.1093/icvts/ivz160. [Epub ahead of print]

PMID:
31243436
2.

A 5-month history of fever and dry cough in a 67-year-old man.

Depetri F, Tarsia P, Donato MF, Invernizzi F, Cugno M.

Intern Emerg Med. 2019 Jun 18. doi: 10.1007/s11739-019-02132-1. [Epub ahead of print] No abstract available.

PMID:
31214884
3.

The effect of primary graft dysfunction after lung transplantation on parenchymal remodeling detected by quantitative computed tomography.

Salito C, Aliverti A, Tosi D, Pennati F, Carrinola R, Rosso L, Tarsia P, Morlacchi LC, Nosotti M, Palleschi A.

J Thorac Dis. 2019 Apr;11(4):1213-1222. doi: 10.21037/jtd.2019.04.19.

4.

Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure.

Cairoli E, Eller-Vainicher C, Morlacchi LC, Tarsia P, Rossetti V, Pappalettera M, Arosio M, Chiodini I, Blasi F.

Osteoporos Int. 2019 Jun;30(6):1255-1263. doi: 10.1007/s00198-019-04893-z. Epub 2019 Feb 23.

PMID:
30798331
5.

Lung Allocation Score System: First Italian Experience.

Palleschi A, Benazzi E, Rossi CF, Torelli R, Passamonti SM, Pellegrini C, Lucianetti A, Tarsia P, Meloni F, Parigi P, Nosotti M.

Transplant Proc. 2019 Jan - Feb;51(1):190-193. doi: 10.1016/j.transproceed.2018.02.214. Epub 2018 Jun 30.

PMID:
30736973
6.

Application of machine learning to predict obstructive sleep apnea syndrome severity.

Mencar C, Gallo C, Mantero M, Tarsia P, Carpagnano GE, Foschino Barbaro MP, Lacedonia D.

Health Informatics J. 2019 Jan 30:1460458218824725. doi: 10.1177/1460458218824725. [Epub ahead of print]

PMID:
30696334
7.

Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders in Cystic Fibrosis Lung Transplant Recipients: A Case Series.

Mendogni P, Henchi S, Morlacchi LC, Tosi D, Nosotti M, Tarsia P, Gregorini AI, Rosso L.

Transplant Proc. 2019 Jan - Feb;51(1):194-197. doi: 10.1016/j.transproceed.2018.05.032. Epub 2018 Jun 30.

PMID:
30655153
8.

Surveillance Transbronchial Biopsy Program to Evaluate Acute Rejection After Lung Transplantation: A Single Institution Experience.

Tosi D, Carrinola R, Morlacchi LC, Tarsia P, Rossetti V, Mendogni P, Rosso L, Righi I, Damarco F, Nosotti M.

Transplant Proc. 2019 Jan - Feb;51(1):198-201. doi: 10.1016/j.transproceed.2018.04.073. Epub 2018 Jun 28.

PMID:
30655138
9.

Transplant options for end stage chronic obstructive pulmonary disease in the context of multidisciplinary treatments.

Santambrogio L, Tarsia P, Mendogni P, Tosi D.

J Thorac Dis. 2018 Oct;10(Suppl 27):S3356-S3365. doi: 10.21037/jtd.2018.04.166. Review.

10.

Infections after lung transplantation.

Nosotti M, Tarsia P, Morlacchi LC.

J Thorac Dis. 2018 Jun;10(6):3849-3868. doi: 10.21037/jtd.2018.05.204. Review.

11.

Neutrophil elastase in bronchiectasis.

Gramegna A, Amati F, Terranova L, Sotgiu G, Tarsia P, Miglietta D, Calderazzo MA, Aliberti S, Blasi F.

Respir Res. 2017 Dec 19;18(1):211. doi: 10.1186/s12931-017-0691-x. Review.

12.

Antibiotic therapy, supportive treatment and management of immunomodulation-inflammation response in community acquired pneumonia: review of recommendations.

Mantero M, Tarsia P, Gramegna A, Henchi S, Vanoni N, Di Pasquale M.

Multidiscip Respir Med. 2017 Oct 5;12:26. doi: 10.1186/s40248-017-0106-3. eCollection 2017. Review.

13.

Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection.

Mantero M, Gramegna A, Pizzamiglio G, D'Adda A, Tarsia P, Blasi F.

Multidiscip Respir Med. 2017 Feb 7;12:2. doi: 10.1186/s40248-016-0083-y. eCollection 2017.

14.

A new approach to detect early lung functional impairment in very light smokers.

Rizzi M, Tarsia P, La Spina T, Cristiano A, Frassanito F, Macaluso C, Airoldi A, Vanni S, Legnani D.

Respir Physiol Neurobiol. 2016 Sep;231:1-6. doi: 10.1016/j.resp.2016.05.010. Epub 2016 May 17.

PMID:
27224237
15.

Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia.

Brambilla AM, Aliberti S, Prina E, Nicoli F, Del Forno M, Nava S, Ferrari G, Corradi F, Pelosi P, Bignamini A, Tarsia P, Cosentini R.

Intensive Care Med. 2014 Jul;40(7):942-9. doi: 10.1007/s00134-014-3325-5. Epub 2014 May 10. Erratum in: Intensive Care Med. 2014 Aug;40(8):1187.

PMID:
24817030
16.

Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis.

Aliberti S, Brambilla AM, Chalmers JD, Cilloniz C, Ramirez J, Bignamini A, Prina E, Polverino E, Tarsia P, Pesci A, Torres A, Blasi F, Cosentini R.

Respir Res. 2014 Mar 4;15:27. doi: 10.1186/1465-9921-15-27.

17.

Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective.

Aliberti S, Cilloniz C, Chalmers JD, Zanaboni AM, Cosentini R, Tarsia P, Pesci A, Blasi F, Torres A.

Thorax. 2013 Nov;68(11):997-9. doi: 10.1136/thoraxjnl-2013-203384. Epub 2013 Jun 17.

PMID:
23774884
18.

Postural effects on lung and chest wall volumes in late onset type II glycogenosis patients.

Remiche G, Lo Mauro A, Tarsia P, Ronchi D, Bordoni A, Magri F, Comi GP, Aliverti A, D'Angelo MG.

Respir Physiol Neurobiol. 2013 May 1;186(3):308-14. doi: 10.1016/j.resp.2013.03.004. Epub 2013 Mar 15.

PMID:
23501539
19.

Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication.

Blasi F, Tarsia P, Mantero M, Morlacchi LC, Piffer F.

Ther Clin Risk Manag. 2013;9:55-64. doi: 10.2147/TCRM.S41131. Epub 2013 Feb 12.

20.

Extracorporeal membrane oxygenation with spontaneous breathing as a bridge to lung transplantation.

Nosotti M, Rosso L, Tosi D, Palleschi A, Mendogni P, Nataloni IF, Crotti S, Tarsia P.

Interact Cardiovasc Thorac Surg. 2013 Jan;16(1):55-9. doi: 10.1093/icvts/ivs433. Epub 2012 Oct 24.

21.

Lung transplantation and posterior reversible encephalopathy syndrome: a case series.

Rosso L, Nosotti M, Mendogni P, Palleschi A, Tosi D, Montoli M, Pappalettera M, Tarsia P, Santambrogio L.

Transplant Proc. 2012 Sep;44(7):2022-5. doi: 10.1016/j.transproceed.2012.06.027.

PMID:
22974897
22.

Understanding the burden of pneumococcal disease in adults.

Blasi F, Mantero M, Santus P, Tarsia P.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:7-14. doi: 10.1111/j.1469-0691.2012.03937.x. Epub 2012 Aug 6. Review.

23.

Artificial lung as an alternative to mechanical ventilation in COPD exacerbation.

Crotti S, Lissoni A, Tubiolo D, Azzari S, Tarsia P, Caspani L, Gattinoni L.

Eur Respir J. 2012 Jan;39(1):212-5. doi: 10.1183/09031936.00021111. No abstract available.

24.

Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia.

Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, Tarsia P, Mantero M, Blasi F.

Clin Infect Dis. 2012 Feb 15;54(4):470-8. doi: 10.1093/cid/cir840. Epub 2011 Nov 21.

PMID:
22109954
25.

Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia.

Aliberti S, Ramirez J, Cosentini R, Brambilla AM, Zanaboni AM, Rossetti V, Tarsia P, Peyrani P, Piffer F, Blasi F.

Respir Med. 2011 Nov;105(11):1732-8. doi: 10.1016/j.rmed.2011.07.006. Epub 2011 Aug 6.

26.

Late lung retransplantation using extracorporeal membrane oxygenation as a bridge: case report.

Nosotti M, Rosso L, Tosi D, Palleschi A, Mendogni P, Crotti S, Lissoni A, Ferrero S, Tarsia P, Santambrogio L.

Transplant Proc. 2011 May;43(4):1198-200. doi: 10.1016/j.transproceed.2011.01.131.

PMID:
21620088
27.

[Tako-tsubo syndrome in a young man with amyotrophic lateral sclerosis. A case report].

Massari FM, Tonella T, Tarsia P, Kirani S, Blasi F, Magrini F.

G Ital Cardiol (Rome). 2011 May;12(5):388-91. doi: 10.1714/643.7506. Italian.

PMID:
21593960
28.

Non-invasive continuous positive airway pressure in monolateral lung transplant patient with pneumonia and IPF.

Aliberti S, Andrisani MC, Tarsia P, Trevisan R, Cosentini R, Longhi L, Pappalettera M, Nosotti M, Blasi F.

Monaldi Arch Chest Dis. 2010 Dec;73(4):169-75.

PMID:
21434566
29.

Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial.

Cosentini R, Brambilla AM, Aliberti S, Bignamini A, Nava S, Maffei A, Martinotti R, Tarsia P, Monzani V, Pelosi P.

Chest. 2010 Jul;138(1):114-20. doi: 10.1378/chest.09-2290. Epub 2010 Feb 12.

PMID:
20154071
30.

Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy.

Blasi F, Bonardi D, Aliberti S, Tarsia P, Confalonieri M, Amir O, Carone M, Di Marco F, Centanni S, Guffanti E.

Pulm Pharmacol Ther. 2010 Jun;23(3):200-7. doi: 10.1016/j.pupt.2009.12.002. Epub 2009 Dec 16.

PMID:
20025989
31.

Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia.

Aliberti S, Blasi F, Zanaboni AM, Peyrani P, Tarsia P, Gaito S, Ramirez JA.

Eur Respir J. 2010 Jul;36(1):128-34. doi: 10.1183/09031936.00130909. Epub 2009 Nov 19.

32.

Chlamydophila pneumoniae.

Blasi F, Tarsia P, Aliberti S.

Clin Microbiol Infect. 2009 Jan;15(1):29-35. doi: 10.1111/j.1469-0691.2008.02130.x. Review.

33.

Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection.

Cosentini R, Tarsia P, Canetta C, Graziadei G, Brambilla AM, Aliberti S, Pappalettera M, Tantardini F, Blasi F.

Respir Res. 2008 May 30;9:48. doi: 10.1186/1465-9921-9-48.

34.

Clinical applications of azithromycin microspheres in respiratory tract infections.

Blasi F, Aliberti S, Tarsia P.

Int J Nanomedicine. 2007;2(4):551-9. Review.

35.

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis.

Blasi F, Aliberti S, Tarsia P, Santus P, Centanni S, Allegra L.

Int J Chron Obstruct Pulmon Dis. 2007;2(1):27-31. Review.

36.

Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice.

Blasi F, Aliberti S, Allegra L, Piatti G, Tarsia P, Ossewaarde JM, Verweij V, Nijkamp FP, Folkerts G.

Respir Res. 2007 Nov 19;8:83.

37.

Brain retention of contrast medium with transient neurological syndrome following coronary angiography.

Massari F, Salerno MG, Tarsia P.

J Cardiovasc Med (Hagerstown). 2007 Nov;8(11):969-70. No abstract available.

PMID:
17906490
38.

Telithromycin in lower respiratory tract infections.

Blasi F, Cazzola M, Tarsia P, Aliberti S, Baldessari C, Valenti V.

Future Microbiol. 2006 Jun;1(1):7-16. Review.

PMID:
17661681
39.

100 years of respiratory medicine: pneumonia.

Blasi F, Aliberti S, Pappalettera M, Tarsia P.

Respir Med. 2007 May;101(5):875-81. Epub 2007 Mar 26. Review.

40.

Mixed community-acquired lower respiratory tract infections.

Tarsia P, Aliberti S, Pappalettera M, Blasi F.

Curr Infect Dis Rep. 2007 Jan;9(1):14-20.

PMID:
17254500
41.

A 13-year-old female with shortness of breath and pleuritic chest pain.

Aliberti S, Falleni M, Tarsia P, Vago G, Zerbi P, Barberis M, Valenti V, Blasi F.

Eur Respir J. 2006 Oct;28(4):876-82. No abstract available.

42.

The 2001 meningitis epidemic in south Chad.

Bregani ER, Tarsia P, Pujades E, Van Tien T, Arioli M, Ziglioli E.

Minerva Med. 2006 Apr;97(2):161-73. English, Italian.

PMID:
16760855
43.

Value of short-course antimicrobial therapy in community-acquired pneumonia.

Blasi F, Tarsia P.

Int J Antimicrob Agents. 2005 Dec;26 Suppl 3:S148-55. Review.

PMID:
16543076
44.

Chlamydia pneumoniae and Mycoplasma pneumoniae.

Blasi F, Tarsia P, Aliberti S, Cosentini R, Allegra L.

Semin Respir Crit Care Med. 2005 Dec;26(6):617-24. Review.

PMID:
16388430
45.

Highlights on the appropriate use of fluoroquinolones in respiratory tract infections.

Blasi F, Tarsia P, Aliberti S, Santus P, Allegra L.

Pulm Pharmacol Ther. 2006;19 Suppl 1:11-9. Epub 2005 Nov 28. Review.

PMID:
16310389
46.

Azithromycin and lower respiratory tract infections.

Blasi F, Cazzola M, Tarsia P, Cosentini R, Aliberti S, Santus P, Allegra L.

Expert Opin Pharmacother. 2005 Oct;6(13):2335-51. Review.

PMID:
16218893
47.

Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease.

Allegra L, Blasi F, Diano P, Cosentini R, Tarsia P, Confalonieri M, Dimakou K, Valenti V.

Respir Med. 2005 Jun;99(6):742-7. Epub 2004 Dec 10.

48.

Strategic targets of essential host-pathogen interactions.

Blasi F, Tarsia P, Aliberti S.

Respiration. 2005 Jan-Feb;72(1):9-25. Review.

PMID:
15753628
49.

The heparins and cancer: review of clinical trials and biological properties.

Castelli R, Porro F, Tarsia P.

Vasc Med. 2004 May;9(3):205-13. Review.

PMID:
15675186
50.

Potential role of antibiotics in the treatment of asthma.

Blasi F, Cosentini R, Tarsia P, Allegra L.

Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):237-42. Review.

PMID:
15379591

Supplemental Content

Loading ...
Support Center